Clinical trial 1206 - HNCG
A randomized phase II study to evaluate the efficacy and safety of Chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic, androgen receptor (AR) expressing, salivary gland cancer (SGCs)
Cancers | |
---|---|
Organ | Oral cavity and lips |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Non |
Sponsor | EORTC |
EudraCT Identifier | 2013-000314-38 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01969578 |
Inclusion criteria | metastatic RECIST 1.1 |
Last update |